Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huh, Myung Sook | - |
dc.contributor.author | Lee, Seung-Young | - |
dc.contributor.author | Park, Sangjin | - |
dc.contributor.author | Lee, Seulki | - |
dc.contributor.author | Chung, Hyunjin | - |
dc.contributor.author | Lee, Sojin | - |
dc.contributor.author | Choi, Yongseok | - |
dc.contributor.author | Oh, Yu-Kyoung | - |
dc.contributor.author | Park, Jae Hyung | - |
dc.contributor.author | Jeong, Seo Young | - |
dc.contributor.author | Choi, Kuiwon | - |
dc.contributor.author | Kim, Kwangmeyung | - |
dc.contributor.author | Kwon, Ick Chan | - |
dc.date.accessioned | 2024-01-20T19:03:07Z | - |
dc.date.available | 2024-01-20T19:03:07Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2010-06-01 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/131341 | - |
dc.description.abstract | Here, we designed a new nano-sized siRNA carrier system composed of biocompatible/biodegradable glycol chitosan polymer (GC) and strongly positively charged polyethylenimine (PEI) polymers. In order to make a stable and tumor-homing nano-sized carrier, each polymer was modified with hydrophobic 5 beta-cholanic acid, and they were simply mixed to form self-assembled GC-PEI nanoparticles (GC-PEI NPs), due to the strong hydrophobic interactions of 5 beta-cholanic acids in the polymers. The freshly prepared GC-PEI NPs showed a stable nanoparticle structure (350 nm) and they presented a strongly positive-charged surface (zeta potential = 23.8) that is enough to complex tightly with negatively charged RFP-siRNAs, designed for inhibiting red fluorescent protein (RFP) expression. The siRNA encapsulated nanoparticles (siRNA-GC-PEI NPs) formed more compact and stable nanoparticle structures (250 nm) at 1: 5 weight ratio of siRNA to GC-PEI nanoparticles. In vitro RFP expressing B16F10 tumor cell (RFP/B16F10) culture system, the siRNA-GC-PEI NPs presented a rapid time-dependent cellular uptake profile within 1 h. Moreover, the internalized siRNA-GC-PEI NPs lead to specific mRNA breaks down. Furthermore, our new formulation of siRNA-GC-PEI NPs presented a significant inhibition of RFP gene expression of RFP/B16F10-bearing mice, due to their higher tumor-targeting ability. These results revealed the promising potential of GC-PEI NPs as a stable and effective nano-sized siRNA delivery system for cancer treatment. (C) 2010 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER | - |
dc.subject | SMALL INTERFERING RNAS | - |
dc.subject | IN-VIVO DELIVERY | - |
dc.subject | CHITOSAN NANOPARTICLES | - |
dc.subject | CELLULAR UPTAKE | - |
dc.subject | CARRIERS | - |
dc.subject | GROWTH | - |
dc.subject | INFECTION | - |
dc.subject | RELEASE | - |
dc.subject | COMPLEX | - |
dc.subject | ACID | - |
dc.title | Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jconrel.2010.02.023 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.144, no.2, pp.134 - 143 | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 144 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 134 | - |
dc.citation.endPage | 143 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000278652800004 | - |
dc.identifier.scopusid | 2-s2.0-77952668878 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | SMALL INTERFERING RNAS | - |
dc.subject.keywordPlus | IN-VIVO DELIVERY | - |
dc.subject.keywordPlus | CHITOSAN NANOPARTICLES | - |
dc.subject.keywordPlus | CELLULAR UPTAKE | - |
dc.subject.keywordPlus | CARRIERS | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordAuthor | Glycol chitosan | - |
dc.subject.keywordAuthor | Polyethylenimine | - |
dc.subject.keywordAuthor | siRNA | - |
dc.subject.keywordAuthor | Nanoparticle delivery system | - |
dc.subject.keywordAuthor | Tumor-targeting delivery | - |
dc.subject.keywordAuthor | Cancer treatment | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.